Skip to main content

Topic

anti corruption

1,480 published works

  1. Legal Futures Blog

    SRA and FCA “need statutory powers” to view privileged material

    By Legal Futures

    Amersi: Judgment awaited in challenge to SRA powersThe government needs to give both the Solicitors Regulation Authority (SRA) and Financial Conduct Authority (FCA) explicit powers to see privileged material when…

  2. FCPA Professor

    The Back And Forth Continues

    By Mike Koehler

    Silly? Warranted? Somewhere in between? Who knows. But the back and forth between the DOJ and Judge Nicholas Garaufis (E.D.N.Y.) in connection with the DOJ’s consent motion to dismiss in…

  3. FCPA Professor

    A Closer Look At Judge Garaufis’s Decision Not To Dismiss The FCPA Charges

    By Mike Koehler

    In 2024, the DOJ criminally charged various individuals in connection with an alleged Indian bribery scheme. (See here for the prior post). This recent post highlighted how Judge Nicholas Garaufis (E.D.N.Y.) granted…

  4. Global Investigations & Compliance Review

    From the World Cup to the Courtroom: Wayne Barnes on Sport and the Law

    By Squire Patton Boggs

    On the latest episode of Bad News, Good Lawyers, Tom Firestone, head of our Government Investigations & White Collar Practice, welcomes Wayne Barnes, a Squire Patton Boggs partner, one of…

  5. FCPA Professor

    Judge Dismisses Fraud Charges Against Adanis – FCPA Charges Against Other Defendants Remain

    By Mike Koehler

    In 2024, the DOJ criminally charged various individuals in connection with an alleged Indian bribery scheme. (See here for the prior post). Gautam Adani (a citizen of India and founder of the…

  6. FCPA Professor

    Flawed Esquenazi Decision Continues To Impact FCPA Enforcement

    By Mike Koehler

    In 2014, the 11th Circuit released its decision in U.S. v. Esquenazi. The case was, and remains, the only appellate court decision in Foreign Corrupt Practices Act history to substantively address the FCPA’s…

  7. China Law Insight

    从《贪污贿赂解释(二)》看医药企业CSO模式的刑事风险与合规转向

    By King & Wood

    作者:吴巍 刘艳洁 补政洋 过去一段时间内,部分医药企业将CSO视为营销体系中的“防火墙”。推广活动由第三方实施,费用通过市场推广费、咨询费、学术服务费等形式流转,即便下游出现违规行为,上游药企也会试图以“外包关系”“第三方独立行为”为由切割责任。 阅读更多

  8. FCPA Professor

    Berko Convicted Of FCPA And Related Offenses

    By Mike Koehler

    In the latest example of the Trump administration’s retreat from FCPA enforcement (or some still maintain), earlier today Asante Berko (a former Executive Director of Goldman Sachs International) was convicted…

  9. FCPA Professor

    Checking In On The Adani Matter

    By Mike Koehler

    Several posts in late June and July (see here, here, here, here) checked in on the U.S. v. Adani et al matter and the pending DOJ consent motion requesting that U.S.…

  10. FCPA Professor

    2004 Was An Important Year In Terms Of “Modern FCPA Enforcement”

    By Mike Koehler

    The Foreign Corrupt Practices Act is approaching the big 5-0 as the law was enacted in 1977. 2004 – hard to believe – was 22 years ago and that year…